Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Sonia Philipose Sonia Philipose |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Philipose, S; Konya, V; Lazarevic, M; Pasterk, L; Marsche, G; Frank, S; Peskar, BA; Heinemann, A; Schuligoi, R;
Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation.
BMC Pharmacology and Toxicology 2012
18th Scientific Symposium of the Austrian
Pharmacological Society (APHAR). 2012; -Austrian Pharmacological Society (APHAR) Joint Meeting with the Croatian, Serbian and Slovenian Pharmacological Societies; SEP 20-21,2012; Graz, Austria.
[Poster]
FullText
Philipose, S; Offner, M; Konya, V; Heinemann, A; Schuligoi, R
PGE2 INHIBITS THROMBOGENESIS VIA THE EP4 RECEPTOR IN A PROTEIN KINASE C MEDIATED PATHWAY
BASIC CLIN PHARMACOL. . 2011; 109: 98-98.-10th Congress of the European Association for Clinical Pharmacology and Therapeutics; JUN 26-29, 2011; Budapest, HUNGARY.
[Poster]
Web of Science
Sreckovic, I; Birner-Gruenberger, R; Philipose, S; Holzer, M; Marsche, G; Desoye, G; Lang, U; Wadsack, C
APOLIPOPROTEINS (APO) ACCOUNTS FOR THE ANTI-INFLAMMATORY FUNCTION OF FETAL HDL
PLACENTA. 2011; 32(9):A112-A112.-Meeting of the International-Federation-of-Placenta-Associations (IFPA); SEP 14-17, 2011; Geilo, NORWAY.
[Poster]
Web of Science
Philipose, S; Ofner, M; Heinemann, A; Schuligoi, S
MSc.
Meeting Abstracts of the 16th Symposium of the Austrian Pharmacological Society, BMC Pharmacology. 2010; 10(1):-16th Scientific Symposium of the Austrian Pharmacological Society (APHAR); Nov 26-27; Vienna.
[Poster]
FullText
Philipose, S; Ofner, M; Heinemann, A; Schuligoi, S
The Prostaglandin E2 receptor EP$- a potential target for antithrombotic therapy.
Joint ZMF & Doctoral day; Nov 5-6, 2010; Graz. 2010.
[Oral Communication]
Philipose, S; Ofner, M; Heinemann, A; Schuligoi, S
Prostaglandin E2 acts via the EP4 receptor to inhibit platelet aggregation
Joint Doctoral & ZMF day; Nov 5-6, 2009; Graz. 2009.
[Poster]
Philipose,S; Ofner,M; Heinemann,A; Schuligoi,R
Prostaglandin E2 acts via the EP4 receptor to inhibit platelet aggregation
BMC Pharmacology2009; 9 (S 2):A8--15th Scientific Symposium of the Austrian Pharmacological Society (APHAR); 19-21 November 2009; Graz.
[Poster]